The document outlines specific organisms that are commonly misidentified.
(checking for cracks, contamination, or hemolysis) rather than full organism-based performance testing. This saves labs substantial time and money while maintaining high safety standards. ANSI Webstore You can purchase or view more details on the official CLSI M22-A3 product page or access a preview through the ANSI Webstore specific media types are included in the 27 newly exempt categories? clsi m22a3 pdf
Accurate culture media performance is the backbone of clinical microbiology. If a culture medium fails to perform correctly, it can lead to false-negative results, delayed diagnoses, and inappropriate patient treatment. What is CLSI M22-A3? The document outlines specific organisms that are commonly
Defining strict quality assurance metrics that commercial producers must meet before shipping products. ANSI Webstore You can purchase or view more
The document outlines the responsibilities for both manufacturers and users to ensure media performance.
CLSI M22-A3 is a document that outlines the performance standards for susceptibility testing of mycobacteria, nocardioform, and other actinomycetes. The guideline provides a framework for laboratories to perform accurate and reliable susceptibility testing, which is crucial for guiding patient care and antimicrobial therapy.
Laboratories must practice First-In, First-Out (FIFO) inventory management to ensure media do not expire before use.